Article Data

  • Views 1518
  • Dowloads 130

Original Research

Open Access

Veno-venous two-site cannulation versus veno-venous double lumen ECMO: complications and survival in infants with respiratory failure


1,Division of Neonatology Pediatric Intensive Care and Neuropediatrics Medical University of Vienna

DOI: 10.22514/SV72.102012.7 Vol.7,Issue 2,October 2012 pp.40-46

Published: 29 October 2012

*Corresponding Author(s): MICHAEL HERMON E-mail:


Objective. To compare complications and survival between the two-site veno-venous versus the veno-venous double lumen extracorporeal membrane oxygenation (ECMO) in infants with respiratory failure. 

Methods. The Extracorporeal Life Support Organization (ELSO, Ann Arbor, Michigan) provided the registry database, collec-ted between 1999-2009 for this research project. During this period, 9086 infants 􀀁 7 kg birth weight (BW) were treated with ECMO. From these children, those who were older than 32 days and received veno-venous extracorporeal membrane oxygenation (VV ECMO), were extracted for analysis. From a total of 270 infants who met the inclusion criteria, 236 infants were treated with veno-venous double lumen (VVDL) ECMO and 34 infants received VV two-site ECMO. ELSO records were reviewed for the following information: demographic data, type of ventilation, ventilator days and settings during ECMO, complications during ECMO and survival.

Results. Eighty-seven percent (n=236) of infants were cannulated with VVDL and 13% (n=34) with VV two-site cannulation. Twenty-four hours after ECMO onset, ventilator settings were significantly higher in the VV two-site group. Median ECMO duration was significantly shorter in the VV two-site group (137(90/208) vs. 203(128/336) hours, p=0.01). Total complication rate and survival rates (71% in the VVDL group and 56% in the VV two-site group) were not significantly different. Conclusion. Both cannulation modes for ECMO are safe for use in infants with respiratory failure. The decision regarding which technique should be used for this group of patients depends mainly on best practice experience of the individual ECMO center and on the technical equipment routinely used by the center.


ECMO, infants, respira-tory failure, complications, survival

Cite and Share

MICHAEL HERMON,JOHANN GOLEJ,GEHAN MOSTAFA,GUDRUN BURDA,REGINA VARGHA,GERHARD TRITTENWEIN. Veno-venous two-site cannulation versus veno-venous double lumen ECMO: complications and survival in infants with respiratory failure. Signa Vitae. 2012. 7(2);40-46.


1. Extracorporeal Life Support Organization. Registry Report, International Summary. 2011 Jan. Available from: URL:http://www.elsonet. org.

2. Pettignano R, Fortenberry JD, Heard ML, Labuz MD, Kesser KC, Tanner AJ, et al. Primary use of the venovenous approach for extracor-poreal membrane oxygenation in pediatric acute respiratory failure. Pediatr Crit Care Med 2003;4:291-8.

3. Roberts N, Westrope C, Pooboni SK, Mulla H, Peek GJ, Sosnowski AW, et al. Venovenous extracorporeal membrane oxygenation for respiratory failure in inotrope dependent neonates. ASAIO 2003;49:568-71.

4. Skarsgard ED, Salt DR, Lee SK. Extracorporeal Life Support Organization Registry. Venovenous extracorporeal membrane oxygenation in neonatal respiratory failure. Does routine, cephalic jugular drainage improve outcome? J Pediatr Surg 2004;39:672-6.

5. Swaniker F, Kolla S, Moler F, Custer J, Grams R, Bartlett R, et al. Extracorporeal life support outcome for 128 patients with respiratory failure. J Pediatr Surg 2000;35:197-202.

6. Peek GJ, Firmin RK, Moore HM, Sosnowski AW. Cannulation of neonates for venovenous extracorporeal life support. Ann Thorac Surg 1996;61:1851-2.

7. Goretsky MJ, Martinasek D, Warner BW. Pulmonary hemorrhage: a novel complication after extracorporeal life support. J Ped Surg 1996;31(9):1276-81.

8. Finer NN, Tierney AJ, Ainsworth W. Venovenous extracorporeal membrane oxygenation: The effects of proximal internal jugular cannulation. J Ped Surg 1996;31(10):1391-5.

9. Reickert CA, Schreiner RJ, Bartlett RH, Hirschl RB. Percutaneous access for venovenous extracorporeal life support in neonates. J Ped Surg 1998;33:365-9.

10. Trittenwein G, Golej J, Burda G, Hermon M, Marx M, Wollenek G, et al. Neonatal and pediatric extracorporeal membrane oxygenation using nonocclusive blood pumps: The Vienna experience. Artif Org 2001;25(12):994-9.

11. Brandt I. Growth dynamics of low-birth-weight infants with emphasis on the perinatal period. In: Falkner F, Tanner JM, editors. Human Growth. 2nd ed. New York (NY): Plenum Press; 1986. p. 415-75.

12. Kolla S, Awad SS, Rich PB, Schreiner RJ, Hirschl RB, Bartlett RH. Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg 1997;226:544-66.

13. Green T, Moler F, Goodman DM. Probability of survival after prolonged extracorporeal membrane oxygenation in pediatric patients with acute respiratory failure. Crit Care Med 1995;23:1132-9.

14. Van Meurs K, Lally KP, Peek G, Zwischenberger JB. ECMO Extracorporeal Cardiopulmonary Support in critical care. 2nd ed. Ann Arbor (MI): ELSO; 2005.

15. Stolar CJ, Dilon PW. Modification of cardiopulmonary hemodynamics and vasoactive mediators by extracorporeal membrane oxygenation in newborns lambs. J Pediatr Surg 1990;25:33-7.

16. Nowlen TT, Salley SO, Whittlesey GC, Kundu SK, Maniaci NA, Henry RL, et al. Regional blood flow distribution during extracorporeal membrane oxygenation in rabbits. J Thorac Cardiovasc Surg 1989;98:1138-43.

17. Anderson HL, Snedecor SM, Otsu T, Bartlett RH. Multicenter comparison of conventional venovenous access versus venovenous double-lumen catheter access in newborn infants undergoing extracorporeal membrane oxygenation. J Pediatr Surg 1993;28:530-4.

18. Kinsella JP, Gestemann DR, Rosenberg AA. The effect of extracorporeal membrane oxygenation on coronary perfusion and regional blood flow distribution. Ped Res 1992;31:80-4.

19. Hirschl RB, Heiss KF, Bartlett RH. Severe myocardial dysfunction during extracorporeal membrane oxygenation. J Pediatr Surg 1992;27:48-53.

20. Kimball TR, Daniels SR, Weiss RG, Meyer RA, Hannon DW, Ryckman FC, et al. Changes in cardiac function during extracorporeal mem-brane oxygenation for persistent pulmonary hypertension in newborn infants. J Pediatr 1991;118:431-6.

21. Short BL, Walker LK, Bender KS, Traystman RJ. Impairment of cerebral autoregulation during extracorporeal membrane oxygenation in newborn lambs. Ped Res 1993;33:289-94.

22. Fukuda S, Aoyama M, Yamada Y, Saitoh N, Honjoh T, Hasegawa T, et al. Comparison of venoarterial versus venovenous access in the cerebral circulation of newborns undergoing extracorporeal membrane oxygenation. Pediatr Surg Int 1999;15:78-84.

23. Zwischenberger JB, Steinhorn RH, Bartlett RH. ECMO Extracorporeal Cardiopulmonary Support in Critical Care. 2nd ed. Ann Arbor (MI): ELSO; 2000.

24. Pettignano R, Clark RH, Cornish JD. Principles and practice of venovenous extracorporeal membrane oxygenation. In: Zwischenberg JB, Steinhorn RH, Bartlett RH, editors. ECMO Extracorporeal Cardiopulmonary Support in Critical Care. 2nd ed. Ann Arbor (MI): ELSO; 2000.

p. 111-3.

25. Bartlett RH, Roloff DW, Custer JR, Younger JG, Hirschl RBet al. Extracorporeal Life Support: The University of Michigan experience. JAMA 2000;283:904-8.

26. Zahraa JN, Moler FW, Annich GM, Maxvold NJ, Bartlett RH, Custer JR. Venovenous versus venoarterial extracorporeal life support for pediatric respiratory failure: are there differences in survival and acute complications? Crit Care Med 2000;28:521-5.

27. Zabrocki LA, Brogan TV, Statler KD, Poss WB, Rollins MD, Bratton SL. Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality. Crit Care Med 2011;39:364-70.

28. Green TP, Timmons OD, Fackler JC, Moler FW, Thompson AE, Sweeney MF. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Crit Care Med 1996;24:323-9.

29. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Int Care Med 2009;35:2105-14.

30. O´Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring diagnosis: ICD code accuracy. Health Serv Res 2005;40:1620-39.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time